Evidence map›Paper›PMID 34323037›Full record

ArticleSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition2021

[Biofilm Eradication Four-Step Strategy: Study of Using Self-Assembled Azithromycin/Rhamnolipid Nanoparticles for Removing

Ya-Ting Dong, Peng-Yu Li, Ying-Ying Sun, Yi-Qin Rao, Shi-Hui Yu, Hai-Yan Hu

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ya-Ting DongSchool of Pharmaceutical Science, Sun Yat-Sen University, Guangzhou 510006, China.
Peng-Yu LiSchool of Pharmaceutical Science, Sun Yat-Sen University, Guangzhou 510006, China.
Ying-Ying SunSchool of Pharmaceutical Science, Sun Yat-Sen University, Guangzhou 510006, China.
Yi-Qin RaoSchool of Pharmaceutical Science, Sun Yat-Sen University, Guangzhou 510006, China.
Shi-Hui YuSchool of Pharmaceutical Science, Sun Yat-Sen University, Guangzhou 510006, China.
Hai-Yan HuSchool of Pharmaceutical Science, Sun Yat-Sen University, Guangzhou 510006, China.
Sun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the

methodsAZI-RHL NPs were prepared and characterized. The minimum inhibitory concentration (MIC) of AZI-RHL NPs on planktonic

resultsThe AZI-RHL NPs had a particle size of about 121 nm and were negatively charged on the surface, displaying a high encapsulation efficiency and a high drug loading capacity of 96.72% and 45.08% for AZI, respectively and 99.38% and 53.07% for RHL, respectively. The MIC of AZI-RHL NPs on planktonic

conclusionAZI-RHL NPs were able to effectively enhance the removal of

Indexed as

NanoparticlesPseudomonas aeruginosaAnti-Bacterial AgentsAzithromycinBiofilmsGlycolipidsHumansMicrobial Sensitivity TestsAnti-Bacterial AgentsAzithromycinGlycolipidsrhamnolipidAntibiofilmAzithromycinPseudomonas aeruginosaRhamnolipidSelf-assembled nanoparticles

Identifiers

PMID34323037
PMCPMC10409402
OpenAlexW3183606532

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.